Page last updated: 2024-08-18

isomethyleugenol and Cancer of Ovary

isomethyleugenol has been researched along with Cancer of Ovary in 76 studies

Research

Studies (76)

TimeframeStudies, this research(%)All Research%
pre-19903 (3.95)18.7374
1990's10 (13.16)18.2507
2000's15 (19.74)29.6817
2010's27 (35.53)24.3611
2020's21 (27.63)2.80

Authors

AuthorsStudies
Bai, J; Chen, C; Liu, J; Qian, C; Wang, Y; Wei, J; Xing, Y1
Apanovich, NV; Braga, EA; Brovkina, OI; Burdennyy, AM; Dmitriev, AA; Filippova, EA; Fridman, MV; Karpukhin, AV; Kazubskaya, TP; Kushlinskii, NE; Loginov, VI; Lukina, SS; Pronina, IV; Stilidi, IS; Uroshlev, LA1
Chen, K; Chen, Y; Li, Y; Liao, N; Liu, J; Luo, M; Mo, Z; Wang, M; Xiao, J; Zeng, J; Zhang, Q; Zou, J1
Gao, Y; Tan, M; Xie, T; Yang, H1
Gao, J; Li, F; Tan, M; Wang, S; Xu, H; Zhu, L1
Chen, QH; Chen, YL; He, SL; Tian, Q; Yi, SJ1
Li, X; Wang, X; Wu, J1
Xing, J; Yin, X; Zhang, M; Zhao, S; Zhou, J; Zhu, X1
Chan, JY; Chen, J; Deng, P; Guan, P; Hong, JH; Huang, Y; Liu, L; Liu, S; Ong, CK; Sun, Y; Tan, J; Teh, BT; Wang, P; Wang, Y; Wen, S; Xiao, R; Xiong, Y; Yin, J; Yu, Q; Yu, Z; Zeng, X1
Hong, L; Wang, S; Wang, X; Zheng, L; Zhu, G1
Guan, W; Li, X; Liu, H; Wang, F; Xu, G; Yuan, J1
Chen, L; Chen, Q; Gao, W; Li, T; Li, Y; Lin, L; Long, L; Sha, C; Wei, H; Xing, J; Xu, W; Yang, M; Zhang, M; Zhao, S; Zhu, X1
Chen, X; Ji, H; Jiang, M; Liu, H; Liu, Y; Song, G; Wang, ZW; Ye, M; Zhu, X1
Czogalla, B; Han, N; Hester, A; Jeschke, U; Kuhn, C; Mahner, S; Mayr, D; Rottmann, M; Schmoeckel, E; Trillsch, F1
Cardenas, H; Chaparala, A; Chen, J; Davuluri, RV; Huang, H; Ji, Y; Kandpal, M; Matei, D; Tanner, EJ; Wang, Y; Zhao, G1
Li, Q; Wang, Q; Zhang, J; Zhang, Q1
An, N; Chen, XJ1
Choi, YJ; Hur, S; Jung, Y; Kang, BS; Kim, M; Lee, S; Liu, J1
Dai, ZY; Fang, JD; Jin, SM; Leng, HL; Luo, HQ1
Kwon, JS1
Guan, Q; Guo, H; Hong, D; Ji, J; Liu, J; Ren, Q; Zhang, C; Zhang, Q1
Dobrovic, A1
Alejo, S; Hoang, N; Khal, A; Lee, L; Leng, F; Lu, F; Qi, D; Saxena, L; Sun, H; Zhang, C; Zhang, H1
Dvorakova, P; Hernychova, L; Nenutil, R; Novotny, MV; Rehulka, P; Rehulkova, H; Valik, D; Vojtesek, B; Zahradnikova, M1
Cai, J; Guo, J; Huang, Z; Liu, T; Tang, G; Wang, Z; Yu, L; Zhu, Y1
Braga, EA; Burdennyy, AM; Dmitriev, AA; Filippova, EA; Kazubskaya, TP; Khodyrev, DS; Kushlinskii, NE; Kushlinsky, DN; Loginov, VI; Pronina, IV; Utkin, DO1
Cao, CH; Chen, G; Feng, XX; Feng, ZH; Gao, QL; Li, MC; Liu, D; Ma, D; Tan, JH; Wan, DY; Wang, H; Wang, J; Wu, P; Xi, BX; Xi, L; Yang, ZY; Ye, F; Zhang, XX; Zhou, JF1
Arend, RC; Jones, BA; Varambally, S1
Huang, S; Lau, B; Lau, WB; Tang, K; Wang, H; Wang, W; Wang, X; Wei, Y; Xu, L; Yang, Q; Yang, Y; Yang, Z; Yi, T; Zhao, L; Zhao, X; Zhou, N; Zhou, S1
Lan, R; Li, S; Lu, F; Ma, Y; Wang, Q; Yu, M; Zhang, H; Zhang, X1
Anderson, WF; Anglesio, MS; Bodelon, C; Bowtell, DDL; Brinton, LA; Doherty, JA; Killian, JK; Lissowska, J; Matsuno, R; Ramus, SJ; Sampson, JN; Sherman, ME; Talhouk, A; Wentzensen, N1
Bachvarov, D; Bachvarova, M; Gregoire, J; Keita, M; Morin, C; Plante, M; Renaud, MC; Sebastianelli, A; Trinh, XB1
Falahi, F; Hospers, GA; Huisman, C; Kazemier, HG; Kok, K; Rots, MG; van der Vlies, P1
Berger, M; Blanchard, V; Braicu, EI; Ehlers, M; Hoppe, B; Kaup, M; Petzold, D; Schwedler, C; Sehouli, J; Tauber, R1
Costa, SD; Eggemann, H; Ignatov, A; Ignatov, T; Kalinski, T; Roessner, A1
Chen, J; Fu, Y; Li, C; Pang, B; Shen, K; Zhao, J1
Cao, JM; Chen, NN; Li, CY; Li, D; Sun, WP; Wang, XX; Zhou, YM1
Jin, P; Li, N; Zhang, C1
Blanco-González, E; Cinti, M; Fernández de la Campa, MR; Iglesias González, T; Montes-Bayón, M1
Cheng, X; Li, X; Lu, W; Mao, Y; Pan, Q; Wan, X; Xie, X1
Davidson, B; Falnes, PØ; Jakobsson, ME; Moen, A1
Kitanaka, C; Kurachi, H; Kuramoto, K; Nagase, S; Ohta, T; Okada, M; Sakaki, H; Seino, M; Seino, S; Suzuki, S; Takeda, H; Watarai, H1
Cardenas, H; Matei, D; Nephew, KP; Vieth, E; Zhao, J1
Czekierdowska, S; Czekierdowski, A; Czuba, B; Danilos, J; Kotarski, J; Sodowska, H; Sodowski, K; Szymanski, M1
Cai, J; Hu, S; Li, Z; Shen, Y; Wang, J; Wang, Z; Xiao, L; Yu, L1
Blanco-Fernández, A; Dempsey, E; Harvey, DJ; Madden, SF; Mariño, K; McCann, A; Peracaula, R; Pérez-Garay, M; Rudd, PM; Saldova, R; Struwe, WB; Watson, JA1
Alley, WR; Goetz, JA; Hussein, A; Mann, BF; Matei, DE; Mechref, Y; Menning, N; Novotny, MV; Svoboda, M; Vasseur, JA1
Lee, C; Lee, HS1
Chang, MC; Chen, CA; Chen, PJ; Cheng, WF; Chiang, YC; Hsieh, CY; Wu, MM1
Andriantsiferana, R; Chaturvedula, VS; Kingston, DG; Miller, JS; Rasamison, VE; Schilling, JK1
Burrows, JF; Chanduloy, S; Donaghy, P; Godwin, AK; Johnston, PG; McIlhatton, MA; Nagar, H; Price, J; Russell, SE; Yeates, K1
Amada, S; Furuya, T; Hirakawa, T; Kawasaki, K; Kawauchi, S; Liu, XP; Oga, A; Sasaki, K1
Horiuchi, A; Konishi, I2
Gaiger, A; Grunt, TW; Kainz, B; Puckmair, K; Tomek, K1
Baudler, M; Beck, JF; Benimetskaya, L; Gekeler, V; Gimmnich, P; Gonser, B; Grebe, C; Hanauer, G; Hofmann, HP; Leja, A; Maier, T; Pieles, U; Römmele, M; Sanders, K; Stein, CA; Wagner, T1
Capo-chichi, CD; Caslini, C; Nicolas, E; Roland, IH; Xu, XX; Yeung, AT1
Case, EA; Conway, PS; Gallion, HH; Pieretti, M; Powell, DE; Turker, MS1
Mann, M; Varmuza, S1
Carcangiu, ML; Han, H; Li, S; Resnik, E; Schwartz, PE; Yang-Feng, TL1
Baranowski, W; Keith, G; Tomaszewski, J1
Crenshaw, T; Hao, Y; Moulton, T; Shields, T; Tycko, B; Zhang, Y1
Driscoll, DJ; Locker, J; Mowery-Rushton, PA; Nicholls, RD; Surti, U1
Götzinger, N; Mueller-Lantzsch, N; Roemer, K; Sauter, M1
Boiocchi, M; Corona, G; Donada, C; Fabris, M; Toffoli, G; Viel, A; Zarrelli, A1
Buekers, T; Buller, RE; Lallas, T; Skilling, JS; Sood, AK1
Boyd, J; Narod, SA1
Fearon, ER1
Baylin, SB; Bonilla, F; Bussaglia, E; Dominguez, G; Esteller, M; Gabrielson, E; Harkes, IC; Herman, JG; Lerma, E; Matias-Guiu, X; Prat, J; Repasky, EA; Schutte, M; Silva, JM1
Chen, CL; Cheng, D; Ip, SM; Ngan, HY; Wong, LC1
Abdul-Karim, FW; Cheng, L; Eble, JN; Gu, J; Michael, H; Roth, LM; Ulbright, TM; Younger, C; Zhang, S1
Agoulnik, A; Arlt, K; Diatchenko, L; Dietel, M; Schäfer, R; Scharff, KM; Schober, H; Sers, C; Siebert, PD; Wiechen, K; Zhumabayeva, B1
Arnold, JM; Chenevix-Trench, G; Cummings, M; Purdie, D1
Dell, A; Fukuda, M; Fukuda, MN; Oates, JE1
Lu, T; Nelson, JH; Sheid, B1
Pillinger, DJ; Wilkinson, R1

Reviews

5 review(s) available for isomethyleugenol and Cancer of Ovary

ArticleYear
The potential regulatory role of RNA methylation in ovarian cancer.
    RNA biology, 2023, Volume: 20, Issue:1

    Topics: Epigenesis, Genetic; Female; Humans; Methylation; Ovarian Neoplasms; RNA

2023
Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer.
    Molecular cancer therapeutics, 2018, Volume: 17, Issue:3

    Topics: Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Lysine; Methylation; Molecular Targeted Therapy; Ovarian Neoplasms; Small Molecule Libraries

2018
Epigenetics in ovarian cancer: premise, properties, and perspectives.
    Molecular cancer, 2018, 07-31, Volume: 17, Issue:1

    Topics: Acetylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histone Acetyltransferases; Histone Deacetylases; Histone Demethylases; Histones; Humans; Methylation; Ovarian Neoplasms

2018
[Mechanism of ovarian cancer metastasis--changes in E-cadherin expression].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: Cadherins; Cell Adhesion; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Methylation; Neoplasm Metastasis; Ovarian Neoplasms; Promoter Regions, Genetic; Transcription Factors

2004
[Prevention of ovarian cancer development].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: Alleles; Asbestos; Clomiphene; Diet; Female; Fertility Agents, Female; Genes, BRCA1; Gonadotropins; Humans; Life Style; Loss of Heterozygosity; Methylation; Obesity; Ovarian Neoplasms; Ovulation; Promoter Regions, Genetic; Risk Factors; Talc

2004

Other Studies

71 other study(ies) available for isomethyleugenol and Cancer of Ovary

ArticleYear
Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Adenosine; Carcinoma, Ovarian Epithelial; Female; Humans; Methylation; Ovarian Neoplasms; RNA Processing, Post-Transcriptional; Tumor Microenvironment

2021
Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
    International journal of molecular sciences, 2022, Jan-24, Volume: 23, Issue:3

    Topics: Carcinoma; Carcinoma, Ovarian Epithelial; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Machine Learning; Methylation; MicroRNAs; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneum; Prognosis; Recurrence; Transcriptome

2022
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis.
    Journal of ovarian research, 2022, Feb-28, Volume: 15, Issue:1

    Topics: Cell Adhesion Molecules; Cell Line, Tumor; Chemokine CXCL11; Computational Biology; Dendritic Cells; Disease Progression; Drug Resistance, Neoplasm; Female; Ferroptosis; Humans; Intercellular Signaling Peptides and Proteins; Interferon Regulatory Factors; Membrane Glycoproteins; Methylation; N-Acetylgalactosaminyltransferases; Nerve Tissue Proteins; Neutrophils; Nuclear Receptor Subfamily 4, Group A, Member 1; Ovarian Neoplasms; Polycystic Ovary Syndrome; Polypeptide N-acetylgalactosaminyltransferase; Prognosis; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Receptors, FSH; Receptors, Interleukin; Receptors, Lysophosphatidic Acid; RNA, Messenger; STAT1 Transcription Factor; Transcriptome; Ubiquitin-Protein Ligases

2022
CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
    Environmental toxicology, 2022, Volume: 37, Issue:8

    Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms; Receptors, Retinoic Acid; Tripartite Motif Proteins; Ubiquitin-Protein Ligases

2022
A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer.
    Carcinogenesis, 2022, 08-30, Volume: 43, Issue:7

    Topics: Carcinoma, Ovarian Epithelial; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms; Prognosis; Tumor Microenvironment

2022
LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter.
    Molecular medicine (Cambridge, Mass.), 2022, 09-13, Volume: 28, Issue:1

    Topics: Carcinoma, Ovarian Epithelial; Eukaryotic Initiation Factor-2B; Female; Humans; Methylation; Methyltransferases; MicroRNAs; Neoplastic Processes; Ovarian Neoplasms; Potassium Channels, Voltage-Gated; Promoter Regions, Genetic; RNA, Long Noncoding

2022
N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
    Epigenomics, 2022, Volume: 14, Issue:23

    Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Apoptosis; Female; Humans; Methylation; Mice; Mice, Nude; Ovarian Neoplasms; Oxidative Stress

2022
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
    Molecular cancer, 2023, 05-20, Volume: 22, Issue:1

    Topics: Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Histones; Humans; Methylation; Ovarian Neoplasms; Polycomb Repressive Complex 2

2023
Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.
    Cancer chemotherapy and pharmacology, 2023, Volume: 92, Issue:1

    Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Methylation; Ovarian Neoplasms; Receptors, CXCR6; RNA; RNA Splicing Factors; Tumor-Associated Macrophages

2023
RBM15‑mediating MDR1 mRNA m
    International journal of oncology, 2023, Volume: 63, Issue:4

    Topics: Female; Humans; Methylation; Ovarian Neoplasms; Paclitaxel; RNA; RNA-Binding Proteins; RNA, Messenger; Signal Transduction

2023
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance.
    Journal of ovarian research, 2023, Sep-06, Volume: 16, Issue:1

    Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; CD8-Positive T-Lymphocytes; Drug Resistance, Neoplasm; Female; Humans; Methylation; Ovarian Neoplasms; RNA, Long Noncoding

2023
Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion.
    Cell death & disease, 2023, 09-22, Volume: 14, Issue:9

    Topics: Arginine; Cell Cycle Proteins; Female; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; Methyltransferases; Nuclear Proteins; Ovarian Neoplasms; Phosphorylation; Pregnancy; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Transcription Factors

2023
H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology.
    International journal of molecular sciences, 2020, Mar-20, Volume: 21, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Calcitriol; Cell Line, Tumor; Cell Proliferation; Epigenesis, Genetic; Female; Histones; Humans; Kaplan-Meier Estimate; Lysine; Methylation; Middle Aged; Multivariate Analysis; Ovarian Neoplasms; Proportional Hazards Models; Receptors, Calcitriol; Survival Analysis

2020
FTO-Dependent
    Cancer research, 2020, 08-15, Volume: 80, Issue:16

    Topics: 3' Untranslated Regions; Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Alternative Splicing; Animals; Ascites; Carcinogenesis; Cell Line, Tumor; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Down-Regulation; Fallopian Tubes; Female; Gene Knockdown Techniques; Heterografts; Humans; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Ovarian Neoplasms; Ovary; RNA Stability; RNA, Messenger; Second Messenger Systems; Sequence Analysis, RNA; Spheroids, Cellular; Tissue Array Analysis; Transcriptome; Tumor Suppressor Proteins

2020
Clinicopathological and immunological characterization of RNA m
    Molecular genetics & genomic medicine, 2021, Volume: 9, Issue:1

    Topics: Adenosine; Biomarkers, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Nerve Tissue Proteins; Nuclear Proteins; Ovarian Neoplasms; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA-Binding Proteins

2021
Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
    Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:1

    Topics: Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Histones; Humans; Lysine; Methylation; Models, Biological; Neoplasm Invasiveness; Ovarian Neoplasms; Protein Binding; RNA, Long Noncoding; Treatment Outcome

2021
Peripheral blood
    Journal of gynecologic oncology, 2021, Volume: 32, Issue:2

    Topics: BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Methylation; Ovarian Neoplasms

2021
LncRNA HOTAIR regulates anoikis-resistance capacity and spheroid formation of ovarian cancer cells by recruiting EZH2 and influencing H3K27 methylation.
    Neoplasma, 2021, Volume: 68, Issue:3

    Topics: Anoikis; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms; RNA, Long Noncoding

2021
Comments on: Peripheral blood
    Journal of gynecologic oncology, 2021, Volume: 32, Issue:2

    Topics: BRCA1 Protein; Female; Humans; Methylation; Ovarian Neoplasms

2021
m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
    Bioengineered, 2021, Volume: 12, Issue:1

    Topics: Adenosine; Databases, Genetic; Female; Gene Regulatory Networks; Humans; Methylation; Neoplasm Invasiveness; Ovarian Neoplasms; Prognosis; RNA; Transcriptome

2021
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk: A Perspective.
    Annals of internal medicine, 2018, 03-06, Volume: 168, Issue:5

    Topics: Female; Humans; Leukocytes; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic

2018
LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein SOX2.
    The Journal of biological chemistry, 2018, 03-09, Volume: 293, Issue:10

    Topics: Amino Acid Substitution; Animals; Cell Line, Tumor; Cells, Cultured; Chromosomal Proteins, Non-Histone; Embryonic Stem Cells; Female; HEK293 Cells; Histone Demethylases; Histone-Lysine N-Methyltransferase; Humans; Methylation; Mice, Inbred C57BL; Mutation; Neoplasm Proteins; Ovarian Neoplasms; Protein Processing, Post-Translational; Protein Stability; Proteolysis; Recombinant Fusion Proteins; RNA Interference; SOXB1 Transcription Factors; Teratocarcinoma

2018
Microgradient separation technique for purification and fractionation of permethylated N-glycans before mass spectrometric analyses.
    Journal of separation science, 2018, Volume: 41, Issue:9

    Topics: Biomarkers, Tumor; Chemical Fractionation; Chromatography; Chromatography, Liquid; Female; Healthy Volunteers; Humans; Methylation; Ovarian Neoplasms; Polysaccharides; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2018
Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.
    International journal of oncology, 2018, Volume: 52, Issue:6

    Topics: AMP-Activated Protein Kinase Kinases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epigenesis, Genetic; Female; Histones; Humans; Metformin; Methylation; Ovarian Neoplasms; Phosphorylation; Polycomb Repressive Complex 2; Protein Kinases

2018
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Gene, 2018, Jul-01, Volume: 662

    Topics: Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; CpG Islands; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histology; Humans; Methylation; MicroRNAs; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Promoter Regions, Genetic; Up-Regulation

2018
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation.
    Nature communications, 2018, 04-30, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Biomarkers, Tumor; CCAAT-Enhancer-Binding Protein-beta; Cell Line, Tumor; Chromatin; Cisplatin; Databases, Factual; DNA-Binding Proteins; Drug Resistance, Neoplasm; Epigenesis, Genetic; Epithelial Cells; Female; GATA1 Transcription Factor; GATA4 Transcription Factor; Histone-Lysine N-Methyltransferase; Histones; Humans; Interferon Regulatory Factor-3; Methylation; Methyltransferases; Nuclear Proteins; Ovarian Neoplasms; Primary Cell Culture; Prognosis; Survival Analysis; Transcription Factors

2018
PHF20L1 antagonizes SOX2 proteolysis triggered by the MLL1/WDR5 complexes.
    Laboratory investigation; a journal of technical methods and pathology, 2018, Volume: 98, Issue:12

    Topics: Animals; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; Female; HEK293 Cells; Histone-Lysine N-Methyltransferase; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Mice, Inbred NOD; Mice, SCID; Myeloid-Lymphoid Leukemia Protein; Ovarian Neoplasms; Protein Stability; Proteolysis; SOXB1 Transcription Factors; Teratoma; Ubiquitination

2018
Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, Oct-01, Volume: 25, Issue:19

    Topics: Carcinoma, Ovarian Epithelial; DNA Copy Number Variations; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms

2019
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.
    Cell cycle (Georgetown, Tex.), 2013, Mar-15, Volume: 12, Issue:6

    Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Core Binding Factor Alpha 2 Subunit; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Humans; Methylation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; RNA Interference; RNA, Small Interfering

2013
Towards sustained silencing of HER2/neu in cancer by epigenetic editing.
    Molecular cancer research : MCR, 2013, Volume: 11, Issue:9

    Topics: Breast Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; HEK293 Cells; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; MCF-7 Cells; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Receptor, ErbB-2; Transcription Factors

2013
Sialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients.
    Electrophoresis, 2014, Volume: 35, Issue:7

    Topics: Case-Control Studies; Electrophoresis, Capillary; Female; Humans; Immunoglobulin G; Methylation; N-Acetylneuraminic Acid; Ovarian Neoplasms; Polysaccharides

2014
BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer.
    Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; BRCA1 Protein; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Female; Humans; Methylation; Middle Aged; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Prognosis; Promoter Regions, Genetic; Taxoids; Young Adult

2014
EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
    Cell biochemistry and biophysics, 2015, Volume: 71, Issue:1

    Topics: Adenosine; Carcinogenesis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Epigenetic Repression; Female; Gene Knockdown Techniques; Histones; Humans; Lysine; Methylation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polycomb Repressive Complex 2; rho GTP-Binding Proteins; RNA, Small Interfering; Survival Analysis; Tumor Suppressor Proteins

2015
BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer.
    Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:16

    Topics: BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Cytokines; Female; Gene Knockdown Techniques; Humans; Methylation; Mutation; NAD; Nicotinamide Phosphoribosyltransferase; Ovarian Neoplasms; Promoter Regions, Genetic

2014
Berberine exhibits antitumor effects in human ovarian cancer cells.
    Anti-cancer agents in medicinal chemistry, 2015, Volume: 15, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Berberine; Cell Line, Tumor; Cell Proliferation; Cisplatin; CpG Islands; Drug Synergism; Female; Humans; Inhibitor of Apoptosis Proteins; Methylation; MutL Protein Homolog 1; Nuclear Proteins; Ovarian Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Survivin

2015
Reversed phase and cation exchange liquid chromatography with spectrophotometric and elemental/molecular mass spectrometric detection for S-adenosyl methionine/S-adenosyl homocysteine ratios as methylation index in cell cultures of ovarian cancer.
    Journal of chromatography. A, 2015, May-08, Volume: 1393

    Topics: Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Chromatography, Reverse-Phase; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Female; Homocysteine; Humans; Methylation; Molecular Weight; Ovarian Neoplasms; S-Adenosylhomocysteine; S-Adenosylmethionine; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2015
Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
    BMC cancer, 2015, Jul-08, Volume: 15

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cyclin G1; DNA Methylation; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genetic Loci; Humans; Methylation; MicroRNAs; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Prognosis; RNA Interference; RNA, Messenger

2015
Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma.
    PloS one, 2015, Volume: 10, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; HSP70 Heat-Shock Proteins; Humans; Kaplan-Meier Estimate; Lysine; Methylation; Middle Aged; Neoplasm Grading; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Prognosis; Proportional Hazards Models; Protein Processing, Post-Translational

2015
GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.
    Anticancer research, 2015, Volume: 35, Issue:12

    Topics: Animals; Cell Differentiation; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Ovarian Neoplasms; Xenograft Model Antitumor Assays

2015
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
    Oncotarget, 2016, Dec-20, Volume: 7, Issue:51

    Topics: Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Indoles; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Protein Binding; Pyridones; RNA Interference; Transforming Growth Factor beta; Zinc Finger E-box Binding Homeobox 2

2016
Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008, Volume: 59 Suppl 4

    Topics: Antigens, CD34; CpG Islands; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Microvessels; Neoplasm Staging; Neovascularization, Pathologic; Ovarian Neoplasms; Ovary; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Thrombospondins

2008
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo.
    Cancer biology & therapy, 2010, Oct-15, Volume: 10, Issue:8

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Survival; Cisplatin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Lysine; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Polycomb Repressive Complex 2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcription Factors; Tumor Burden; Xenograft Model Antitumor Assays

2010
5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer.
    Epigenetics, 2011, Volume: 6, Issue:11

    Topics: Azacitidine; Carcinoma, Ovarian Epithelial; Decitabine; Female; Glycoproteins; Glycosylation; Glycosyltransferases; Humans; Methylation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polysaccharides

2011
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
    Journal of proteome research, 2012, Apr-06, Volume: 11, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Carbohydrate Sequence; Case-Control Studies; Docetaxel; Female; Fucose; Glycomics; Humans; Imatinib Mesylate; Immunoglobulin G; Methylation; Ovarian Neoplasms; Piperazines; Polysaccharides; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Taxoids

2012
Structural analysis of a new cytotoxic demethylated analogue of neo-N-methylsansalvamide with a different peptide sequence produced by Fusarium solani isolated from potato.
    Journal of agricultural and food chemistry, 2012, May-02, Volume: 60, Issue:17

    Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Depsipeptides; Female; Fusarium; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Melanoma; Methylation; Molecular Structure; Ovarian Neoplasms; Peptides, Cyclic; Solanum tuberosum; Spectrometry, Mass, Electrospray Ionization; Uterine Neoplasms

2012
Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients.
    Endocrine-related cancer, 2013, Volume: 20, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Cytoskeletal Proteins; Drug Resistance, Neoplasm; Epigenomics; Female; Gene Silencing; Humans; Methylation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Prognosis; RNA, Small Interfering; Tumor Suppressor Proteins

2013
New cytotoxic bis 5-alkylresorcinol derivatives from the leaves of Oncostemon bojerianum from the Madagascar rainforest.
    Journal of natural products, 2002, Volume: 65, Issue:11

    Topics: Acetylation; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Madagascar; Methylation; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plant Leaves; Plants, Medicinal; Primulaceae; Resorcinols; Stereoisomerism; Tumor Cells, Cultured

2002
Altered expression of the septin gene, SEPT9, in ovarian neoplasia.
    The Journal of pathology, 2003, Volume: 201, Issue:4

    Topics: Adult; Azacitidine; Base Sequence; Cell Line, Tumor; DNA, Circular; Female; Fetus; Gene Expression Regulation, Neoplastic; GTP Phosphohydrolases; Humans; Methylation; Mutation; Ovarian Neoplasms; Protein Splicing; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Septins; Transcription, Genetic

2003
Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
    The Journal of pathology, 2004, Volume: 204, Issue:3

    Topics: Adolescent; Adult; beta Catenin; Cell Cycle Proteins; Cell Transformation, Neoplastic; Child; Child, Preschool; CpG Islands; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cytoskeletal Proteins; DNA, Neoplasm; Female; Genes, p16; Germinoma; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Methylation; Mutation; Neoplasm Proteins; Ovarian Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Trans-Activators

2004
An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
    Biochemical and biophysical research communications, 2005, Apr-22, Volume: 329, Issue:4

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; ErbB Receptors; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Quinazolines; Receptor, ErbB-2; Receptors, Retinoic Acid; RNA, Messenger

2005
G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Oligonucleotides, 2006,Spring, Volume: 16, Issue:1

    Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents; B-Lymphocytes; Carcinoma; Cell Line, Tumor; Cytosine; Female; Humans; Lung Neoplasms; Lymphocyte Activation; Methylation; Mice; Mice, Nude; Neoplasms; Oligodeoxyribonucleotides; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Thionucleotides; Xenograft Model Antitumor Assays

2006
Histone modifications silence the GATA transcription factor genes in ovarian cancer.
    Oncogene, 2006, Aug-31, Volume: 25, Issue:39

    Topics: Acetylation; Adaptor Proteins, Signal Transducing; Apoptosis Regulatory Proteins; Carcinoma; Cell Line, Tumor; Female; GATA Transcription Factors; GATA4 Transcription Factor; GATA6 Transcription Factor; Gene Silencing; Genes, Tumor Suppressor; Heterochromatin; Histones; Humans; Lysine; Methylation; Ovarian Neoplasms; Tumor Suppressor Proteins

2006
Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer.
    Human pathology, 1995, Volume: 26, Issue:4

    Topics: Calcitonin; Chromosomes, Human, Pair 17; Female; Humans; Methylation; Ovarian Neoplasms

1995
Genomic imprinting--defusing the ovarian time bomb.
    Trends in genetics : TIG, 1994, Volume: 10, Issue:4

    Topics: Alleles; Animals; Choriocarcinoma; Embryonic and Fetal Development; Female; Gene Expression Regulation; Humans; Male; Mammals; Methylation; Mice; Models, Biological; Oocytes; Ovarian Neoplasms; Parents; Parthenogenesis; Phenotype; Pregnancy; Selection, Genetic; Teratoma; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms

1994
Advanced ovarian carcinoma: molecular evidence of unifocal origin.
    Gynecologic oncology, 1993, Volume: 51, Issue:1

    Topics: Adult; Aged; Alleles; Chromosome Deletion; Cystadenocarcinoma, Papillary; DNA; Dosage Compensation, Genetic; Female; Heterozygote; Humans; Methylation; Middle Aged; Ovarian Neoplasms

1993
[Methylation of DNA in tissue of ovarian malignant tumors in women].
    Ginekologia polska, 1993, Volume: 64, Issue:4

    Topics: Adult; Carcinoma; DNA, Neoplasm; Female; Humans; Methylation; Middle Aged; Ovarian Neoplasms; Sertoli Cell Tumor

1993
Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching.
    American journal of human genetics, 1993, Volume: 53, Issue:1

    Topics: Adult; Alleles; Base Sequence; Chromosomes, Human, Pair 11; Dinucleoside Phosphates; DNA, Neoplasm; Female; Fetus; Humans; Methylation; Molecular Sequence Data; Ovarian Neoplasms; Promoter Regions, Genetic; Teratoma; Wilms Tumor

1993
DNA methylation patterns in human tissues of uniparental origin using a zinc-finger gene (ZNF127) from the Angelman/Prader-Willi region.
    American journal of medical genetics, 1996, Jan-11, Volume: 61, Issue:2

    Topics: Angelman Syndrome; DNA; Female; Genomic Imprinting; Humans; Hydatidiform Mole; Kruppel-Like Transcription Factors; Methylation; Ovarian Neoplasms; Prader-Willi Syndrome; Pregnancy; Repressor Proteins; Restriction Mapping; Teratoma; Transgenes; Zinc Fingers

1996
Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours.
    The Journal of general virology, 1996, Volume: 77 ( Pt 12)

    Topics: Azacitidine; Butyrates; Butyric Acid; DNA Methylation; DNA, Viral; Female; Gene Products, gag; Humans; Male; Methylation; Ovarian Neoplasms; Retroelements; Teratocarcinoma; Testicular Neoplasms; Tumor Cells, Cultured

1996
Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:8

    Topics: Adult; Aged; Ascitic Fluid; Cysteine; Female; Folic Acid; Glycine; Homocysteine; Humans; Methionine; Methylation; Middle Aged; Ovarian Neoplasms; Vitamin B 12

1997
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
    Journal of the National Cancer Institute, 1999, Feb-17, Volume: 91, Issue:4

    Topics: Case-Control Studies; DNA, Neoplasm; Dosage Compensation, Genetic; Evolution, Molecular; Female; Genes, BRCA1; Germ-Line Mutation; Humans; Loss of Heterozygosity; Methylation; Ovarian Neoplasms

1999
Re: Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
    Journal of the National Cancer Institute, 1999, Sep-01, Volume: 91, Issue:17

    Topics: Age Factors; DNA, Neoplasm; Dosage Compensation, Genetic; Female; Genes, BRCA1; Germ-Line Mutation; Humans; Methylation; Ovarian Neoplasms; X Chromosome

1999
BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism?
    Journal of the National Cancer Institute, 2000, Apr-05, Volume: 92, Issue:7

    Topics: Breast Neoplasms; Cadherins; Female; Gene Expression Regulation, Neoplastic; Genes, BRCA1; Humans; Loss of Heterozygosity; Methylation; Mutation; Neoplasms; Ovarian Neoplasms; Promoter Regions, Genetic; Stomach Neoplasms

2000
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Journal of the National Cancer Institute, 2000, Apr-05, Volume: 92, Issue:7

    Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Gene Expression Regulation, Neoplastic; Genes, BRCA1; Humans; Loss of Heterozygosity; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Neoplasm; Transplantation, Heterologous; Tumor Cells, Cultured

2000
P73 gene expression in ovarian cancer tissues and cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:10

    Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Alleles; Blotting, Western; Carcinoma, Endometrioid; CpG Islands; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Cystadenoma, Serous; DNA Methylation; DNA-Binding Proteins; Exons; Female; Genes, Tumor Suppressor; Humans; Loss of Heterozygosity; Lymphocytes; Methylation; Nuclear Proteins; Ovarian Neoplasms; Ovary; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Tumor Protein p73; Tumor Suppressor Proteins

2000
Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential.
    Journal of the National Cancer Institute, 2001, Aug-01, Volume: 93, Issue:15

    Topics: Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; DNA Restriction Enzymes; DNA, Neoplasm; Female; Humans; Methylation; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Polymerase Chain Reaction; Sex Chromosome Aberrations; Trinucleotide Repeat Expansion; X Chromosome

2001
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.
    The American journal of pathology, 2001, Volume: 159, Issue:5

    Topics: Carcinoma; Caveolin 1; Caveolins; Cell Survival; Down-Regulation; Female; Genes, Tumor Suppressor; Humans; Methylation; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Phosphorylation; Tumor Cells, Cultured

2001
Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas.
    British journal of cancer, 2001, Nov-02, Volume: 85, Issue:9

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; DNA Primers; DNA, Neoplasm; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Adhesion Molecule-1; Loss of Heterozygosity; Methylation; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Prognosis; RNA, Messenger; Survival Analysis; Tumor Cells, Cultured

2001
Embryonal lactosaminoglycan. The structure of branched lactosaminoglycans with novel disialosyl (sialyl alpha 2----9 sialyl) terminals isolated from PA1 human embryonal carcinoma cells.
    The Journal of biological chemistry, 1985, Jun-10, Volume: 260, Issue:11

    Topics: Amino Sugars; Carbohydrate Sequence; Cell Line; Chromatography, Affinity; Chromatography, Gel; Female; Humans; Mass Spectrometry; Methylation; Models, Molecular; Ovarian Neoplasms; Polysaccharides; Teratoma

1985
Transfer RNA methylase and transfer RNA methylase-inhibitor activity in normal and malignant human ovarian tissue.
    Cancer research, 1973, Volume: 33, Issue:10

    Topics: Animals; Carbon Radioisotopes; Female; Guanine; Humans; Methylation; Neoplasm Metastasis; Ovarian Neoplasms; Ovary; Rabbits; RNA, Transfer; tRNA Methyltransferases

1973
Initiation of malignant transformation and the significance of changes in transfer RNA methylase enzymes.
    Cancer research, 1971, Volume: 31, Issue:5

    Topics: Animals; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Culture Techniques; Female; Kidney; Kidney Neoplasms; Male; Methylation; Methyltransferases; Mice; Neoplasms; Ovarian Neoplasms; Ovary; Prostate; Prostatic Neoplasms; RNA, Transfer; Transferases

1971